LifeStrands Genomics and Ambry Genetics to Provide Laboratory Testing for Clinical Implementation Pilots in Phase II of Singapore’s National Precision Medicine Programme
SINGAPORE and ALISO VIEJO, Calif. – April 19, 2023 – LifeStrands Genomics and Ambry Genetics have joined forces to provide clinical genetic testing services in